Athira Pharma's total assets for Q3 2024 were $86.25M, a decrease of -22.48% from the previous quarter. ATHA total liabilities were $28.66M for the fiscal quarter, a 2.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.